Higher levels of different muscarinic receptors in the cortex and hippocampus from subjects with Alzheimer's disease

E Scarr, C McLean, B Dean - Journal of Neural Transmission, 2017 - Springer
… This study did report lower radioligand binding in the … the binding of the non-selective
muscarinic receptor agonist [ 3 H]-… in binding to the frontal, temporal, and visual cortices but lower

Muscarinic receptor subtype distribution in the central nervous system and relevance to aging and Alzheimer's disease

EP Lebois, C Thorn, JR Edgerton, M Popiolek, S Xi - Neuropharmacology, 2018 - Elsevier
Muscarinic receptor levels in the cerebellum are low, with the major subtype being M 2 as
revealed by subtype-specific antibodies and radioligand bindingcerebral cortex, hippocampus

Disease-Modifying Effects of M1 Muscarinic Acetylcholine Receptor Activation in an Alzheimer's Disease Mouse Model

EP Lebois, JP Schroeder, TJ Esparza… - ACS chemical …, 2017 - ACS Publications
… The significant decrease in both cortical oAβ levels as well as hippocampal Aβ 42 pathology
observed in our studies and the finding that VU0364572 abolishes the correlation between …

M1 muscarinic acetylcholine receptor dysfunction in moderate Alzheimer's disease pathology

JH Yi, DJ Whitcomb, SJ Park… - Brain …, 2020 - academic.oup.com
… mod-Alzheimer's disease temporal cortex. (A) mAChR1 protein levels are significantly reduced
in the … (B) GluA2 protein levels are also significantly reduced in the Mod-AD group (N = 7) …

Changes in cortical gene expression in the muscarinic M1 receptor knockout mouse: potential relevance to schizophrenia, Alzheimer's disease and cognition

B Dean, E Scarr - npj Schizophrenia, 2021 - nature.com
low levels of cortical muscarinic M1 receptors (CHRM1) in … requiring cortical interactions
with the hippocampus 14 . At the … of low levels of oestrogen, bind oestrogen receptors causing …

… of cholinergic receptor muscarinic 1 (CHRM1) protein in the hippocampus and temporal cortex of a subset of individuals with Alzheimer's disease, Parkinson's disease …

MG Sabbir, RC Speth… - … of Alzheimer's Disease, 2022 - content.iospress.com
cerebral cortex and other areas, significantly contributing to the cognitive decline in AD patients
[… soluble fraction of the pig brain and was found glycosylated due to the binding to glycan-…

[HTML][HTML] Muscarinic Receptors and Alzheimer's Disease: New Perspectives and Mechanisms

M Monaco, H Trebesova, M Grilli - Current Issues in Molecular Biology, 2024 - mdpi.com
… M 1 Rs are widely distributed in the cerebral cortex, hippocampus, … ACh in the brain, the latter,
by binding to mAChRs, increases … reduced cerebral blood flow in the cortex, hippocampus, …

[HTML][HTML] Characterization of binding of antipsychotics to muscarinic receptors using mouse cerebral cortex

K Obara, S Horiguchi, T Shimada, T Ikarashi… - Journal of …, 2019 - Elsevier
Alzheimer's disease (AD) is a neurodegenerative disorder that causes a decline in cognitive
… , the following 16 drugs inhibited specific binding of 0.5 nM [ 3 H]NMS by less than 35%: …

Cholinergic muscarinic M1 and M4 receptors as therapeutic targets for cognitive, behavioural, and psychological symptoms in psychiatric and neurological disorders

D Erskine, JP Taylor, G Bakker, AJH Brown, T Tasker… - Drug discovery today, 2019 - Elsevier
… [(125)I]muscarinic toxin 4 demonstrated decreased binding in the dentate … receptors were
observed to be decreased in the hippocampus and visual cortex but increased in frontal cortex

Targeting the M1 muscarinic acetylcholine receptor in Alzheimer's disease

L Dwomoh, GS Tejeda, AB Tobin - Neuronal Signaling, 2022 - portlandpress.com
receptor (α7 nAChR, red receptor) resulting in lowerbinds to the two classes of receptors;
the G-protein coupled … including hippocampus, neostriatum, and cerebral cortex [64–…